The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Clinical characteristics and chemotherapy options of triple-negative breast cancer: Role of classical CMF regimen.
Min Hee Hur
No relevant relationships to disclose
Tae Ho Kang
No relevant relationships to disclose
Ra Joo Im
No relevant relationships to disclose
Se Won Kim
No relevant relationships to disclose
Chan Seok Yoon
No relevant relationships to disclose
Seung Sang Ko
No relevant relationships to disclose
Haekyung Lee
No relevant relationships to disclose
Ji Hyun Lee
No relevant relationships to disclose
Sung-Soo Kang
No relevant relationships to disclose